What's Happening?
Carla Goulart Peron, MD, the Chief Medical Officer at Royal Philips, has been appointed to the Board of Directors of the Medical Device Innovation Consortium (MDIC). MDIC is a public-private partnership that collaborates with the US Food and Drug Administration
(FDA) and other agencies to ensure patient access to medical device innovations. Dr. Peron brings extensive experience in bridging clinical evidence and innovation, which is expected to strengthen MDIC's mission. Her role at Philips involves leading the global medical and scientific organization, ensuring that innovations are grounded in clinical evidence and patient safety. MDIC works on developing research, toolkits, and frameworks to help manufacturers navigate regulatory approval and maintain quality standards.
Why It's Important?
Dr. Peron's appointment to the MDIC board is significant as it underscores the importance of collaboration between industry leaders and regulatory bodies to advance medical technology. Her expertise is expected to contribute to the development of safer and more effective medical devices, ultimately benefiting patients. The partnership between MDIC and stakeholders like Philips aims to streamline regulatory processes and inform coverage decisions, which can accelerate the availability of innovative medical technologies. This collaboration is crucial for maintaining high standards in medical device quality and ensuring that advancements in healthcare technology are accessible to patients.
